Why GLP-1 Peptide Impurity Analysis Requires More Than a Platform Method

Platform HPLC methods can accelerate peptide impurity analysis, but they don’t always transfer seamlessly between structurally similar molecules. A comparison of semaglutide and tirzepatide shows why systematic method development remains essential for GLP-1 peptides.

Close-up of multiple insulin pen syringes arranged for pharmaceutical production or testing.

GLP-1 receptor agonists have become some of the most successful peptide therapeutics in modern medicine. As more molecules enter development, laboratories need efficient approaches to impurity analysis. Platform HPLC methods offer an attractive starting point because they can often be applied across multiple compounds with only minor adjustments. The question is whether structurally similar GLP-1 peptides behave similarly enough for that strategy to succeed.

To explore this, our scientists investigated the chromatographic behavior of semaglutide and tirzepatide under a range of HPLC conditions. Although both belong to the GLP-1 therapeutic class, the study revealed meaningful differences in retention behavior and impurity separation. Conditions that performed well for one peptide were not always optimal for the other, emphasizing the need for compound-specific method development.

Key takeaways

Structural similarity among GLP-1 peptides does not necessarily translate to similar chromatographic behavior, meaning platform methods may require compound-specific optimization.
Mobile phase composition had a greater influence on peptide selectivity than differences in reversed-phase column chemistry.
Higher column temperatures did not consistently improve impurity resolution and should be evaluated as part of the overall separation strategy.

Structural similarity doesn’t predict chromatographic behavior

For laboratories developing impurity methods, it’s tempting to assume that closely related GLP-1 peptides can be analyzed using the same chromatographic conditions. However, our results showed that even structurally similar molecules can respond differently to identical HPLC conditions.

Semaglutide and tirzepatide displayed different retention characteristics and impurity separation profiles across the conditions evaluated. This suggests that while a common development strategy may be useful, the final method often needs to be optimized for specific molecules under investigation.

Mobile phase drives peptide selectivity

One of the most notable findings was the impact of mobile phase composition on peptide selectivity.

Across the conditions evaluated, mobile phase composition had a greater influence on impurity separation than stationary phase chemistry. This included the choice of organic modifier, such as methanol (MeOH) or acetonitrile (ACN), and acidic additive, such as formic acid (FA) or trifluoroacetic acid (TFA). This trend was observed with both the Thermo Scientific Hypersil GOLD C4 and Thermo Scientific Hypersil GOLD Peptide columns.

The trifluoroacetic acid–containing mobile phases frequently provided better peak shape and resolution than formic acid–based conditions. The comparison between methanol and acetonitrile was less straightforward. Neither solvent consistently outperformed the other. Separation performance varied depending on the specific impurities and overall chromatographic conditions, highlighting the importance of screening mobile phase conditions.

Higher column temperatures don’t always improve resolution

Increasing column temperature is a common strategy in peptide chromatography and often improves resolution. However, that trend wasn’t universal.

In several cases, higher temperatures improved impurity separations, but under different chromatographic conditions they reduced resolution and caused neighboring peaks to coelute (Figure 1). As a result, there’s no one-size-fits-all column temperature setting. Column temperature should be evaluated for each separation because its effect depends on both the method conditions and the compounds being analyzed.

Increasing column temperature often improved impurity resolution, as the left panel shows, but this effect was not observed under all conditions. In the right panel, impurity resolution worsened when temperature increased.

Figure 1. Increasing column temperature often improved impurity resolution, as the left panel shows, but this effect was not observed under all conditions. In the right panel, impurity resolution worsened when temperature increased.

What does this mean for future GLP-1 method development?

As the number of GLP-1 therapeutics grows, analytical laboratories will increasingly face a familiar question: How much of an existing method can be transferred to a new molecule?

Our results found there’s no simple answer.

The most effective separation conditions depended on the specific peptide being analyzed. Rather than searching for a single best method, a more practical approach may be to establish an efficient screening workflow that quickly identifies suitable conditions for each molecule.

The good news is that the workflow can remain consistent, even when the final method does not. Systematic evaluation of columns, mobile phases, additives, and temperature can provide a reliable path toward robust impurity separations across different GLP-1 peptides.

The next time a new GLP-1 molecule arrives in your laboratory, the question may not be whether your existing method works—but how quickly you can identify the conditions that work best.

To learn more about the HPLC method development strategy and final optimized methods for semaglutide and tirzepatide, download the full application note.

Frequently asked questions

Can the same HPLC method be used for different GLP-1 peptides?

Platform HPLC methods can provide an efficient starting point for GLP-1 peptide impurity analysis, but they are not always directly transferable. Even structurally similar peptides may exhibit different retention and selectivity, requiring optimization of the mobile phase, stationary phase, or temperature to achieve adequate impurity separation.

What factors have the greatest impact on GLP-1 peptide impurity separations?

Several chromatographic parameters influence peptide separations, including mobile phase composition, stationary-phase chemistry, and column temperature. In this study, changes to the mobile phase generally had a greater effect on impurity selectivity than switching between reversed-phase column chemistries, highlighting the importance of systematic method screening.

Does increasing column temperature always improve peptide chromatography?

No. Although elevated column temperatures often improve mass transfer and peak shape, they do not consistently improve impurity resolution. Depending on the peptide and chromatographic conditions, higher temperatures may improve separations or reduce resolution by causing neighboring impurity peaks to co-elute.

How should analytical laboratories approach HPLC method development for new GLP-1 peptides?

Rather than relying on a single universal method, laboratories can often achieve better results by using a structured screening workflow. Evaluating key variables such as mobile phase composition, column chemistry, and temperature helps identify the most suitable conditions for each peptide while accelerating overall method development.

Visit us on LinkedIn: #Biopharmaceutical #HPLC #PeptideAnalysis